KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 141 filers reported holding KURA ONCOLOGY INC in Q4 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $566 | +50.1% | 39,349 | -4.7% | 0.00% | 0.0% |
| Q3 2023 | $377 | +16.4% | 41,309 | +34.9% | 0.00% | +33.3% |
| Q2 2023 | $324 | -77.4% | 30,624 | -73.9% | 0.00% | -75.0% |
| Q1 2023 | $1,436 | +39.3% | 117,434 | +41.4% | 0.01% | -20.0% |
| Q4 2022 | $1,031 | -99.9% | 83,040 | -34.0% | 0.02% | -31.8% |
| Q3 2022 | $1,718,000 | +79.1% | 125,749 | +140.3% | 0.02% | +83.3% |
| Q2 2022 | $959,000 | +217.5% | 52,330 | +178.5% | 0.01% | +200.0% |
| Q1 2022 | $302,000 | -17.7% | 18,790 | -4.0% | 0.00% | -20.0% |
| Q3 2021 | $367,000 | +68.3% | 19,581 | +87.0% | 0.01% | +150.0% |
| Q2 2021 | $218,000 | -60.4% | 10,472 | -37.9% | 0.00% | -60.0% |
| Q4 2020 | $551,000 | -35.4% | 16,868 | -39.4% | 0.01% | -70.6% |
| Q3 2020 | $853,000 | +173.4% | 27,843 | +45.3% | 0.02% | +112.5% |
| Q2 2020 | $312,000 | +110.8% | 19,169 | +77.9% | 0.01% | +166.7% |
| Q4 2019 | $148,000 | – | 10,773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |